Yes, DXB had successful phase 2 efficacy results and then struck a deal. 1AD are about to reveal phase 1 results, in healthy subjects (no efficacy), which they revealed in 2021 however now just at a higher dose. This is a head scratcher.
Yes, DXB had successful phase 2 efficacy results and then struck...
Add 1AD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.9¢ |
Change
0.002(7.41%) |
Mkt cap ! $14.75M | |||
| Open | High | Low | Value | Volume |
| 2.8¢ | 2.9¢ | 2.8¢ | $42.31K | 1.469M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 721435 | 2.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.9¢ | 520671 | 2 |
View Market Depth
| Last trade - 11.32am 30/04/2024 (20 minute delay) ? |
|
|||||
|
Last
2.9¢ |
Change
0.002 ( 3.57 %) |
||||
| Open | High | Low | Volume | ||
| 2.8¢ | 2.9¢ | 2.8¢ | 185755 | ||
| Last updated 11.36am 30/04/2024 ? | |||||
| 1AD (ASX) Chart |